PubMed Health⌕ Search

Biomedical subjects

Jennifer M Hunt

Publications and source records attributed to Jennifer M Hunt.

5 recordsLinked to original sources

Top end rural and remote Indigenous women: an Australian population group vulnerable to rubella.

Australian efforts to prevent cases of congenital rubella syndrome have been largely successful, although concerns that eradication has not yet been achieved are ongoing. This paper describes an Australian population group with a vulnerability to rubella which has not previously been reported. Fewer than 75 per cent of Indigenous women from rural and remote communities who gave birth at Royal Darwin Hospital in 1999 and were tested for rubella antenatally had adequate levels of immunity. By comparison Indigenous and non-Indigenous women living in the Darwin urban area had a prevalence of adequate immunity to rubella on antenatal testing of > 90 per cent, similar to estimates for other Australian-born population groups. Action is required to reduce the risk of cases of congenital rubella syndrome occurring in rural and remote Indigenous communities in the Top End, and may be needed in rural and remote settings elsewhere in Australia. Ensuring each child, adolescent and young adult has received two doses of Measles Mumps Rubella vaccine as part of their primary immunization course will provide increased protection. In addition, more women lacking adequate rubella immunity need to be vaccinated postnatally than was found in this study. Providers of women's care would be assisted in this task if laboratories adopted a standardized approach to reporting the results of antenatal rubella serology tests.

Adolescent↗

Are recommendations about routine antenatal care in Australia consistent and evidence-based?

OBJECTIVE: To describe the variability and evidence base of recommendations in Australian protocols and national policies about six aspects of routine antenatal care. DESIGN: Comparison of recommendations from local protocols, national guidelines and research about number of visits, screening for gestational diabetes (GDM), syphilis, hepatitis C (HCV), and HIV, and advice on smoking cessation. SETTING: Australian public hospitals with more than 200 births/year, some smaller hospitals in each State and Territory, and all Divisions of General Practice were contacted in 1999 and 2000. We reviewed 107 protocols, which included 80% of those requested from hospitals and 92% of those requested from Divisions. MAIN OUTCOME MEASURES: Frequency and consistency of recommendations. RESULTS: Recommendations about syphilis testing were notable in demonstrating consistency between local protocols, national policies and research evidence. Most protocols recommended screening for GDM, despite lack of good evidence of its effectiveness in improving outcomes. Specific approaches to screening for GDM varied widely. Coverage and specific recommendations about testing for HIV and HCV were also highly variable. Smoking-cessation information and advice was rarely included, despite good evidence of the effectiveness of interventions in improving outcomes. No national policies about the number of routine visits and smoking cessation could be identified. There were inconsistent national policies for both HIV and GDM screening. CONCLUSIONS: Antenatal care recommended in protocols used in Australia varies, and is not always consistent with national policies or research evidence. Producing and disseminating systematic reviews of research evidence and national guidelines might reduce this variability and improve the quality of Australian antenatal care.

Australia↗

Nurse reporting of adverse events caused by medicines.

Even though all drugs are extensively tested before marketing, the need for continuous postmarketing surveillance is now greater than ever. In 2002, 16,176 adverse drug reaction reports were received, of which 67 per cent related to reactions categorised as 'serious'. Nurse reporting of adverse drug reactions has almost doubled in the past year since nurses were officially allowed to participate in the yellow-card scheme for identifying adverse drug reactions (NT Clinical news, 2 December, p7). Nurses, through their close contact with patients, are ideally placed to be a key source of information on adverse drug reactions in the UK's yellow-card scheme.

Adverse Drug Reaction Reporting Systems↗